Human Identification Market Human Identification Market
Medical Device

Human Identification Market Reach to US$ 3,900.24 million by 2028 with CAGR of 11.4%.

Human Identification is a brand of science deals with the analysis of genetics materials which helps in the identification of an individual on basis of genetics. Human identification has various applications in the field of forensics, paternity test and others.

The human identification market is majorly comprised of top players involving THERMO FISHER SCIENTIFIC INC.; Promega Corporation; Bio-Rad Laboratories, Inc.; QIAGEN; General Electric Company; llumina, Inc.; Eurofins Scientific; Agilent Technologies, Inc.; Hamilton Company; and LGC Limited.

Qiagen N.V. And Thermo Fisher Scientific. – Notable Market Players in Human Identification Market

The companies listed above are implementing various strategies that have resulted in the growth of the company and in turn, have brought about various changes in the worldwide market. Additionally, the companies have adopted several inorganic and organic strategies for accelerating their growth and improving their market position.

Below is the list of the growth strategies done by the players operating in the human identification market:

Year News
January-2022 The company announced new additions to the growing number of applications for QIAcuity, its ultrasensitive digital PCR (dPCR) platform that has set new standards by using so-called nanoplates to process samples in two hours rather than the five hours required by other systems.
June-2021 The company announced a commercialized partnership with San Diego-based human identification specialist Verogen that will provide customers of both companies with superior tools and comprehensive support for human identification (HID) workflows in their laboratories.
October-2021 Research labs performing Sanger sequencing can now use Promega chemistry on any capillary electrophoresis (CE) platform. The ProDye Terminator Sequencing System, launched by Promega Corporation, can be implemented on any CE instrument, including the benchtop Spectrum Compact CE System.
September-2021 Promega launched its benchtop capillary electrophoresis (CE) instrument, the Spectrum Compact CE System, developed in collaboration with Hitachi High-Tech. The personal CE system is an integrated DNA analysis instrument that enables life scientists in laboratories of all sizes to perform Sanger sequencing and fragment analysis at the bench.
April-2020 KeyGene and LGC announced that they have extended their service license agreement to exploit KeyGene’s Sequence-Based Genotyping (SBG) technology for lab services.